Vaccine News and Research

Latest Vaccine News and Research

Excessive intake of simple sugar in adolescents could be a risk factor of psychiatric disorders

There has been a remarkable increase in intake of simple sugar (sucrose, isomerized sugar (corn syrup)) from beverages and diets in modern society. The intake of simple sugars in adolescents in which mental disorders frequently occur is higher than any other generations.

28 Dec 2021

COVID isolation and quarantine period for general population shortened by CDC

Given what we currently know about COVID-19 and the Omicron variant, CDC is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, if asymptomatic, followed by 5 days of wearing a mask when around others.

27 Dec 2021

Uptake of COVID-19 vaccine doses increases before Christmas in England

Thousands more first and second doses were administered last week compared with the week before, as the public are today reminded that the offer of a vaccine is still available and encouraged to come forward to protect themselves against Omicron.

26 Dec 2021

UK Government to send out Get Boosted Now text messages from Boxing Day

From Boxing Day (26 December) people in the UK will receive a text message reminding them to get a booster vaccine to protect us all from the spread of the Omicron.

26 Dec 2021

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.

26 Dec 2021

Study helps explain why mRNA vaccines have been successful at preventing severe COVID-19

Washington University in St. Louis student Julian McCall receives a dose of Pfizer's mRNA-based COVID-19 vaccine.

24 Dec 2021

Scientists identify a new Achilles' heel of influenza virus

Scientists at Scripps Research, University of Chicago and Icahn School of Medicine at Mount Sinai have identified a new Achilles' heel of influenza virus, making progress in the quest for a universal flu vaccine.

24 Dec 2021

Pfizer vaccine associated with lower risk of SARS-CoV-2 infection and hospitalization in middle-aged adults

New findings suggest that the Pfizer-BioNTech mRNA COVID-19 vaccines provide extra protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) than AstraZeneca.

24 Dec 2021

Pfizer-BioNTech booster shot may offer better immunity than a two-dose regimen

A new study suggests that the immune response against severe acute respiratory syndrome coronavirus 2 is greater with a three-dose regimen than a two-dose regimen.

24 Dec 2021

Vaccinated kidney transplant recipients not adequately protected against emerging SARS-CoV-2 variants

Kidney transplant recipients tend to mount impaired antibody responses against emerging SARS-CoV-2 variants after standard two-dose COVID-19 vaccination, according to new research published in CJASN.

23 Dec 2021

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

One dose of Ad5-nCoV (Convidecia), a COVID-19 vaccine developed in China, is 57.5% effective against symptomatic COVID-19 and 91.7% effective against severe COVID-19 disease beginning 28 days postvaccination, according to a phase 3 randomized controlled trial published in The Lancet.

23 Dec 2021

CDC releases updated guidance for contingency and crisis management in healthcare settings

With the growing number of COVID-19 cases from the Omicron variant, and consistent with current understanding of the disease trajectory, CDC is releasing updated guidance for isolation and quarantine for healthcare workers, decreasing their isolation time after infection with COVID-19.

23 Dec 2021

Researchers identify a key influenza epitope that can targeted for developing universal vaccines

A team led by scientists at Weill Cornell Medicine, Scripps Research and the University of Chicago has identified an important site of vulnerability on influenza viruses—a site that future influenza vaccines and antibody therapies should be able to target to prevent or treat infections by a broad set of influenza strains.

23 Dec 2021

Children produce a much more robust antibody response to a SARS-CoV-2 infection than 18+

Scientists compared receptor binding domain antibodies and SARS-CoV-2 neutralizing antibodies in children and adults.

23 Dec 2021

Omicron has enhanced infectivity that is only weakly neutralized by vaccination or prior infection

Scientists used virus-like particles and found that Omicron showed increased infectivity, relative to the B.1 and B.1.1 strains, which was similar to the Delta variant.

23 Dec 2021

Researchers report loss of antibody potency against SARS-CoV-2 Omicron variant

Researchers find that vaccine-mediated protection against SARS-CoV-2 is significantly reduced against the Omicron variant.

23 Dec 2021

Armed Forces members to support the Welsh Ambulance Service NHS Trust

An extra 184 Armed Forces members have been made available to support the Welsh Ambulance Service NHS Trust (WAST), to increase the resilience of emergency responders during the winter period.

23 Dec 2021

Over 4 million doses of University of Oxford-AstraZeneca vaccine donated by UK to Bangladesh

The UK donated over 4 million doses of the University of Oxford-AstraZeneca vaccine, made by Oxford Bio-medica in Oxford and packaged in Wrexham, North Wales, to Bangladesh through the COVAX vaccine sharing mechanism.

23 Dec 2021

Exploring immunity and severe disease caused by the SARS-CoV-2 Omicron variant

A new study describes the findings of a seroprevalence survey intended to establish the infection rates and the incidence of severe COVID-19 through December 15, 2021, in Gauteng, a crowded province that compresses a quarter of the country’s people into less than 2% of its area.

23 Dec 2021

Assessing the clinical severity of the SARS-CoV-2 Omicron variant

A recent preprint examines the proportion of Omicron infection and the risk of severe disease with this variant of SARS-CoV-2.

23 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

Excessive intake of simple sugar in adolescents could be a risk factor of psychiatric disorders

COVID isolation and quarantine period for general population shortened by CDC

Uptake of COVID-19 vaccine doses increases before Christmas in England

UK Government to send out Get Boosted Now text messages from Boxing Day

Cancer patients who had breakthrough COVID-19 remain at high risk for hospitalization, death

Study helps explain why mRNA vaccines have been successful at preventing severe COVID-19

Scientists identify a new Achilles' heel of influenza virus

Pfizer vaccine associated with lower risk of SARS-CoV-2 infection and hospitalization in middle-aged adults

Pfizer-BioNTech booster shot may offer better immunity than a two-dose regimen

Vaccinated kidney transplant recipients not adequately protected against emerging SARS-CoV-2 variants

Ad5-nCoV vaccine safe and effective against symptomatic, severe COVID-19, trials shows

CDC releases updated guidance for contingency and crisis management in healthcare settings

Researchers identify a key influenza epitope that can targeted for developing universal vaccines

Children produce a much more robust antibody response to a SARS-CoV-2 infection than 18+

Omicron has enhanced infectivity that is only weakly neutralized by vaccination or prior infection

Researchers report loss of antibody potency against SARS-CoV-2 Omicron variant

Armed Forces members to support the Welsh Ambulance Service NHS Trust

Over 4 million doses of University of Oxford-AstraZeneca vaccine donated by UK to Bangladesh

Exploring immunity and severe disease caused by the SARS-CoV-2 Omicron variant

Assessing the clinical severity of the SARS-CoV-2 Omicron variant

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in